Healthy Skepticism Library item: 4080

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Morris LA, Banks DB.
New issues in drug advertising and labeling: the five advertising end-runs
Drug Information Journal 1990; 24:639-646

Abstract:

Five marketing practices which are often at variance with FDA drug advertising regulations are discussed: 1. Use of industry-sponsored scientific and educational activities, 2. Activities lacking in scientific legitimacy, 3. Use of public relations, 4. Direct-to-consumer promotion of prescription drug products, and 5. Industry activities related to promotional materials subject to Food and Drug Administration preapproval. Areas of FDA concern, industry trends, and regulatory responses are discussed for each of these practices.

Keywords:
*analysis/United States/Food and Drug Administration/FDA/regulation of promotion/direct-to-consumer advertising/sponsored symposia & conferences/industry generated publicity/DTCA/ATTITUDES REGARDING PROMOTION: REGULATORS AND GOVERNMENT/PROMOTION DISGUISED: SUPPORT FOR CME/PROMOTIONAL TECHNIQUES: DIRECT-TO-CONSUMER ADVERTISING/PROMOTIONAL TECHNIQUES: PUBLIC RELATIONS/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION